Search clinical trials for: Zopiclone 3.75mg pill

Total 3416 results

Salem Anaesthesia Pain Clinic

Completed

Clonidine is Better Than Zopiclone for Insomnia Treatment in Chronic Pain Patients

Pain, Chronic | Insomnia Chronic

Canada
St. Olavs Hospital
Norwegian Institute of Public Health; Norwegian University of Science and Technology and other collaborators

Withdrawn

Driving Simulator Performance After Intake of Zopiclone Sleeping Pills

Automobile Driving
Sunovion

Completed

Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid Arthritis

Arthritis, Rheumatoid | Insomnia

United States
Sunovion

Completed

6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary Insomnia

Primary Insomnia

United States
Sunovion

Completed

Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving Ability

Primary Insomnia

United Kingdom
Sunovion

Completed

Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers

Insomnia

United Kingdom
Sunovion

Completed

Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause

Insomnia

United States
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Recruiting

A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects

Schizophrenia

China
Linda Van Eldik
Duke Clinical Research Institute; Alzheimer's Association

Completed

A MAD Study of TT301/MW189 in Healthy Volunteers

Healthy Adult Volunteers

United States
Bayer

Completed

Dose Proportionality Study With BAY94-8862 IR (Immediate Release) Tablets

Heart Failure

Germany
Cingulate Therapeutics

Recruiting

Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301

ADHD | Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder With Hyperactivity | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit Hyperactivity

United States
Eurofarma Laboratorios S.A.

Completed

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia (Eszo)

INSOMNIA

Brazil
Pharmbio Korea Co., Ltd.

Recruiting

Study of PBK_L1704 for the Treatment of Moderate to Severe Acute Pain After Bunionectomy in South Korea

Acute Pain

Korea, Republic of
Green Cross Corporation
C&R Research, Inc.; CRScube

Unknown

Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis

Gastritis

Korea, Republic of
Sunovion

Completed

Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)

Obstructive Sleep Apnea Syndrome

United States
Sunovion

Completed

A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder

Insomnia | Depressive Disorder, Major

United States
LHL Helse
ResMed; Haukeland University Hospital; University Hospital, Akershus; Stiftelsen... and other collaborators

Completed

Changes in Blood Gases, Disturbance of Breath During Sleep and Cardiovascular Co-morbidity in COPD Patients

Arrhythmias, Cardiac | Pulmonary Disease | Hypoxemia | Hypercapnia | Chronic Obstructive

Norway
JW Pharmaceutical

Completed

Phase 2 Study of URC102 to Assess the Efficacy and Safety in Gout Patients

Hyperuricemia | Gout

Korea, Republic of
RANI Therapeutics

Completed

Study Evaluating PK of Ustekinumab Administered Orally Via RaniPill™ Capsule

Healthy Volunteers

Australia
Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI); Sunovion

Completed

The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea Syndrome

Obstructive Sleep Apnea

United States
Guang'anmen Hospital of China Academy of Chinese...
Tasly Pharmaceuticals, Inc.

Completed

Trial of Tang-min-ling Pills in the Treatment of Type 2 Diabetes

Diabetes Mellitus, Type 2

China
Bayer
University of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory

Completed

Endometrial Safety Study

Postmenopause

Mexico, United States, Italy, Denmark, Austria, Argentina, Brazil, Russian Federation
GlaxoSmithKline

Completed

An Evaluation of Potential Next-day Residual Effects of Eszopiclone in Healthy Volunteers.

Sleep Initiation and Maintenance Disorders | Healthy Subjects

United Kingdom
Utrecht Institute for Pharmaceutical Sciences
Takeda

Completed

Effects of Ramelteon on Driving Ability

Insomnia

Netherlands
Instituto Nacional de Perinatologia Isidro Espinosa...

Completed

Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio (EDIMI216OHE1)

Breast Cancer
Bayer

Completed

A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Hot Flashes | Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Canada
GlaxoSmithKline

Completed

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia

Prostatic Hyperplasia | Benign Prostatic Hyperplasia
The First Affiliated Hospital of Zhengzhou University

Unknown

Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis

Clinical Pregnancy Rate

China
Eisai Co., Ltd.

Completed

A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)

Insomnia

Japan
Taipei Medical University WanFang Hospital

Completed

Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

Non-alcoholic Fatty Liver Disease

Taiwan
Daewon Pharmaceutical Co., Ltd.
Chungnam National University Hospital

Completed

Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition (DW0919-1003)

Healthy

Korea, Republic of
Eisai Co., Ltd.

Completed

A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)

Insomnia

Japan
Idorsia Pharmaceuticals Ltd.

Completed

A Clinical Study to Assess Next-day Driving Performance Following Administration of ACT-541468 in Middle-aged and Elderly Subjects

Healthy

Netherlands
Daewoong Pharmaceutical Co. LTD.

Completed

The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty

Central Precocious Puberty

Korea, Republic of
Shanghai Pharmaceuticals Holding Co., Ltd

Completed

Hydroxytriptolide in Active Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate (T8)

Rheumatoid Arthritis

China
University of Alabama at Birmingham

Completed

Effect of Gut-Cued Eating on BMI and Efficacy of Open-Label Placebo to Augment Weight Loss (GCE)

Obesity | Body Weight | Eating Behavior | Hunger

United States
Chong Kun Dang Pharmaceutical

Completed

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

Diabetes Mellitus, Type II

Korea, Republic of
Transcept Pharmaceuticals

Completed

Driving Performance After Middle of the Night Administration of 3.5 mg Zolpidem Tartrate Sublingual Tablet

Insomnia

Netherlands
Aileron Therapeutics, Inc.

Completed

Phase 1 Safety Study of ALRN-5281 in Healthy Subjects

Growth Hormone Deficiency

United States
Sunovion

Completed

Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Insomnia | Attention Deficit Hyperactivity Disorder

United States
Ahram Canadian University

Completed

Relation Between Forward Head Posture and Incidence of Headache in Obese Adults

Neck Pain | Headache | Obese

Egypt
Gangnam Severance Hospital

Completed

Orlistat/Phentermine Versus Placebo/Phentermine

Obesity | Overweight

Korea, Republic of
Eisai Inc.
Purdue Pharma LP

Completed

Study to Evaluate the Effect of Lemborexant Versus Placebo on Driving Performance in Healthy Adult and Elderly Subjects

Healthy Participants

Netherlands
Peking Union Medical College Hospital
The Second Hospital of Hebei Medical University; China-Japan Friendship Hospital and other collaborators

Unknown

Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke. (AGNH2018)

Acute Ischemic Stroke

China
Sunovion

Completed

Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia

Insomnia | Attention Deficit Hyperactivity Disorder

United States
Alborz Medical University

Completed

Effect of Dexamethasone on Labor Induction

Pregnancy | Dexamethasone

Iran, Islamic Republic of
NYU Langone Health

Completed

The Effect of Transjugular Intraheptic Portosystemic Shunt (TIPS) on Gastrointestinal Motility and the Gut Microbiota

Cirrhosis

United States
Laboratorios Andromaco S.A.

Completed

Bioavailability of Eszopiclone 3.0 mg With Regards to Reference Product

Bioequivalence

India
Fudan University

Not yet recruiting

RWE About QOL and Compliance of Patients With OFS in China

Quality of Life | Breast Cancer | Hormone Receptor-positive Breast Cancer

China
Massachusetts General Hospital
Beth Israel Deaconess Medical Center; Mclean Hospital

Completed

Effects of Eszopiclone on Sleep and Memory in Schizophrenia

Schizophrenia

United States

Search clinical trials for: Zopiclone 3.75mg pill

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations